Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-18-012008

President and CEO sold 19,578 shares at $29.43 ($576,141)

  • President and CEO acquired 19,578 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
McCarthy Sean A. President and CEO 2018-03-01 Option exercise +10,516 $1.57 $16,562 15,159 D: show line 1 in the form
McCarthy Sean A. President and CEO 2018-03-01 Option exercise +9,000 $1.13 $10,205 24,159 D: show line 2 in the form
McCarthy Sean A. President and CEO 2018-03-01 Option exercise +62 $0.95 $59 24,221 D: show line 3 in the form
McCarthy Sean A. President and CEO 2018-03-01 Sale −19,578 $29.43 $576,141 4,643 D: show line 4 in the form
Open-market sales · 19,578 sh · avg $29.43 · $576,141

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
McCarthy Sean A. President and CEO 2018-03-01 Option exercise · Stock Option (Right to Buy) −10,516 194,804 D: show line 5 in the form
McCarthy Sean A. President and CEO 2018-03-01 Option exercise · Stock Option (Right to Buy) −9,000 328,143 D: show line 6 in the form
McCarthy Sean A. President and CEO 2018-03-01 Option exercise · Stock Option (Right to Buy) −62 66,752 D: show line 7 in the form
Loading xslF345X03/doc1.xml…